Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.72% |
| 2 | Healthcare | 11.35% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGM
3301
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $7.16M | ﹤0.01% |
547,059
-44,165
| -7% | -$669K |
|
|
SEVN
3302
Seven Hills Realty Trust
SEVN
$176M
| $7.13M | ﹤0.01% |
781,993
+15,808
| +2% | +$165K |
|
|
OPI
3303
DELISTED
Office Properties Income Trust
OPI
| $7.13M | ﹤0.01% |
507,566
+13,213
| +3% | +$248K |
|
3304
VanEck Pharmaceutical ETF
PPH
$985M
| $7.13M | ﹤0.01% |
106,005
-83,234
| -44% | -$6.13M |
|
3305
First Bancorp
FBNC
$2.74B
| $7.11M | ﹤0.01% |
194,312
-20,906
| -10% | -$769K |
|
3306
Eastern Bankshares
EBC
$5.4B
| $7.1M | ﹤0.01% |
361,474
-13,262
| -4% | -$265K |
|
3307
Century Aluminum
CENX
$4.62B
| $7.1M | ﹤0.01% |
1,344,266
-296,386
| -18% | -$2.25M |
|
3308
TaskUs
TASK
$688M
| $7.09M | ﹤0.01% |
440,342
+125,523
| +40% | +$2.22M |
|
|
AXIA
3309
DELISTED
AXIA Energia
AXIA
| $7.09M | ﹤0.01% |
1,114,380
+451,701
| +68% | +$3.13M |
|
|
MORF
3310
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $7.08M | ﹤0.01% |
250,217
-161,300
| -39% | -$4.5M |
|
3311
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.9B
| $7.08M | ﹤0.01% |
170,822
-3,689
| -2% | -$172K |
|
3312
Constellium
CSTM
$4.01B
| $7.08M | ﹤0.01% |
698,005
-124,993
| -15% | -$1.66M |
|
|
RC
3313
Ready Capital
RC
$306M
| $7.07M | ﹤0.01% |
697,334
+184,781
| +36% | +$2.39M |
|
|
BELFB
3314
Bel Fuse Inc Class B
BELFB
$4.19B
| $7.07M | ﹤0.01% |
279,902
+25,470
| +10% | +$598K |
|
3315
Fidelity Value Factor ETF
FVAL
$1.38B
| $7.07M | ﹤0.01% |
176,570
-73,613
| -29% | -$3.29M |
|
3316
Nuveen Select Tax-Free Income Portfolio
NXP
$902M
| $7.06M | ﹤0.01% |
541,459
-29,531
| -5% | -$412K |
|
|
SASR
3317
DELISTED
Sandy Spring Bancorp Inc
SASR
| $7.04M | ﹤0.01% |
199,572
-30,089
| -13% | -$1.19M |
|
3318
Alvotech
ALVO
$1.37B
| $7.03M | ﹤0.01% |
1,039,920
+1,038,128
| +57,931% | +$8.01M |
|
3319
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.22B
| $7.03M | ﹤0.01% |
317,660
+11,955
| +4% | +$299K |
|
3320
Immunocore
IMCR
$1.74B
| $7.03M | ﹤0.01% |
149,750
+126,403
| +541% | +$6.02M |
|
3321
National Bank Holdings
NBHC
$1.94B
| $7.02M | ﹤0.01% |
189,869
-6,728
| -3% | -$270K |
|
|
CD
3322
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $7.02M | ﹤0.01% |
869,031
-1,658,842
| -66% | -$12.8M |
|
3323
Sprott Gold Miners ETF
SGDM
$666M
| $6.99M | ﹤0.01% |
327,763
-34,353
| -9% | -$761K |
|
3324
iShares Russell Top 200 Value ETF
IWX
$4.04B
| $6.99M | ﹤0.01% |
121,114
-2,415
| -2% | -$153K |
|
3325
Jakks Pacific
JAKK
$294M
| $6.99M | ﹤0.01% |
361,599
+174,684
| +93% | +$3.59M |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.